JPH0815258A - Immunological determination reagent and determination method - Google Patents

Immunological determination reagent and determination method

Info

Publication number
JPH0815258A
JPH0815258A JP14621394A JP14621394A JPH0815258A JP H0815258 A JPH0815258 A JP H0815258A JP 14621394 A JP14621394 A JP 14621394A JP 14621394 A JP14621394 A JP 14621394A JP H0815258 A JPH0815258 A JP H0815258A
Authority
JP
Japan
Prior art keywords
immunological
reaction
reagent
antigen
monoalcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14621394A
Other languages
Japanese (ja)
Inventor
Hiromi Iijima
裕己 飯嶋
Kunihiro Imaizumi
邦博 今泉
Takeo Yamagata
武夫 山県
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Showa Denko Materials Co Ltd
Original Assignee
Hitachi Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Chemical Co Ltd filed Critical Hitachi Chemical Co Ltd
Priority to JP14621394A priority Critical patent/JPH0815258A/en
Publication of JPH0815258A publication Critical patent/JPH0815258A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

PURPOSE:To carry out highly precise determination with high reproducibility, within a narrow dispersion, and without bubbling during the determination by determining an antigen-antibody reaction based on optical turbidity by using a reagent component produced by either containing or combining a soluble acyclic monoalcohol. CONSTITUTION:Wonoalcohols of acyclic hydrocarbons with 1-30 carbon number are among soluble acyclic monoalcohols to be contained in or combined with a constituent reagent and above all, n-octylalcohol is most effective and most preferable. It is preferable to adjust the concentration of a soluble acyclic monoalcohol existing in the reaction solution during the reaction to be 0.001-10%v/v, especially to be 0.001-1%V/V. As a reaction medium for a sample to be determined, water or a buffer of a physiological saline solution containing 0.1-0.2M/l NaCl at pH 6-9 is preferable. To determine an antigen-antibody reaction from the optical turbidity, for example, an immunological turbidimetric method, a latex immunological turbidimetric method, an optochemical enzyme immunological method, etc., can be applied.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、抗原抗体反応を光学的
な濁度として測定するための免疫学的測定試薬及び測定
方法に関する。詳しくは、測定値のバラツキの少ない免
疫学的測定試薬及び測定方法に関する。
TECHNICAL FIELD The present invention relates to an immunological measuring reagent and a measuring method for measuring an antigen-antibody reaction as optical turbidity. More specifically, the present invention relates to an immunological measuring reagent and a measuring method with little variation in measured values.

【0002】[0002]

【従来の技術】現在、医学や臨床検査の分野において、
ヒト検体中(血中、尿中)の種々の生体物質、例えば、
血漿蛋白や種々の凝固線溶系の蛋白、ホルモン、薬物、
各種細菌、梅毒、クラミジア、ウイルス等やこれらの抗
体等、数多くの項目の測定のために、抗原抗体反応に基
づく免疫学的測定法が広く用いられている。また、近年
は、微量化、迅速化、簡便化、自動化等の顧客のニーズ
に対応した検出法や試薬の開発や改良がなされている。
2. Description of the Related Art Currently, in the fields of medicine and clinical examination,
Various biological substances in human samples (blood, urine), for example,
Plasma proteins and various coagulation / fibrinolytic system proteins, hormones, drugs,
An immunological assay method based on an antigen-antibody reaction is widely used for the measurement of various items such as various bacteria, syphilis, chlamydia, viruses and the like, and antibodies thereof. Further, in recent years, detection methods and reagents have been developed and improved in response to customer needs such as miniaturization, speedup, simplification, and automation.

【0003】免疫学的測定は、その抗原抗体反応を利用
するものであり、通常、抗原検出のためには、被検抗原
に対する抗体を、また、抗体検出のためには、被検抗体
に対する抗原を試薬に用いている。光学的免疫測定法と
しては、検出の手段により、免疫比濁法、ラテックス免
疫比濁法、酵素免疫測定法、化学発光酵素免疫測定法
等、様々な測定法が用いられている。各種抗体または抗
原を感作したラテックス粒子を使用し、ラテックスと検
体中の被検抗原または被検抗体との反応凝集物を光学的
に測定する方法が提案され、普及し(特公昭58−11
575号公報、特公昭62−43138号公報、特公昭
62−55103号公報等)、最近は、専用の分析装置
や自動分析装置を用いて抗原または抗体を定量的に検出
することも行われている。
The immunological assay utilizes the antigen-antibody reaction, and usually, an antibody against a test antigen is used for detecting an antigen, and an antigen against a test antibody is used for detecting an antibody. Is used as a reagent. As the optical immunoassay, various immunoassays such as an immunoturbidimetric assay, a latex immunoturbidimetric assay, an enzyme immunoassay, and a chemiluminescent enzyme immunoassay are used depending on the detection means. A method of optically measuring a reaction aggregate of a latex and a test antigen or a test antibody in a sample using latex particles sensitized with various antibodies or antigens has been proposed and spread (Japanese Patent Publication No. 58-11).
575, JP-B-62-43138, JP-B-62-55103, etc.), and recently, an antigen or antibody has been quantitatively detected using a dedicated analyzer or automatic analyzer. There is.

【0004】さらに、抗原または抗体を不溶性担体に支
持(感作)し、これと検出すべき抗体または抗原を反応
させ、洗浄後、酵素、蛍光物質、ビオチン等で標識した
抗体を反応させ、洗浄後それぞれの活性の強度または酵
素活性を測定することにより、体液成分中の抗原または
抗体の存在を検出する蛍光抗体法や酵素免疫測定法が広
く行なわれ、最近は、酵素免疫測定法と化学発光を組み
合わせた化学発光酵素免疫測定法も用いられるようにな
っている。
Further, an antigen or antibody is supported (sensitized) on an insoluble carrier, and this is reacted with the antibody or antigen to be detected, and after washing, an antibody labeled with an enzyme, a fluorescent substance, biotin or the like is reacted and washed. Afterwards, fluorescent antibody methods and enzyme immunoassays have been widely performed to detect the presence of antigens or antibodies in body fluid components by measuring the intensity of each activity or enzyme activity. A chemiluminescent enzyme immunoassay, which is a combination of these, has also been used.

【0005】[0005]

【発明が解決しようとする課題】しかし、上記の光学的
な免疫測定では、ときに測定値の異常や再現性(ばらつ
き)が問題となる。測定値の再現性を向上させるため、
また濁り物質の影響を回避させるため、各種界面活性
剤、ポリエチレングリコール等の添加が試みられてい
る。しかし、これらは逆に試薬の粘度等を上昇させ、測
定値の異常を来すこともある。また、特開平4−340
467号公報では、ポリエチレングリコール等の反応増
感剤を含有する免疫測定試薬を使用する前に、10℃以
上の温度で10分間加温してから測定する方法を開示し
ている。しかし、この方法には、恒温器や恒温槽が必要
となり、操作に手間もかかる等の問題がある。本発明者
らは、上記課題を解決すべく種々検討した結果、多くの
原因は、検出時の気泡の発生にあることを見出し、本発
明を完成させるに至った。
However, in the above-mentioned optical immunoassay, sometimes abnormalities and reproducibility (dispersion) of measured values become a problem. To improve the reproducibility of measured values,
Further, in order to avoid the influence of turbid substances, addition of various surfactants, polyethylene glycol, etc. has been attempted. However, on the contrary, these may increase the viscosity of the reagent and the like, which may cause abnormal measurement values. In addition, JP-A-4-340
Japanese Patent No. 467 discloses a method in which an immunoassay reagent containing a reaction sensitizer such as polyethylene glycol is heated at a temperature of 10 ° C. or higher for 10 minutes and then measured. However, this method requires a thermostat and a thermostat, and has a problem that the operation is troublesome. As a result of various studies to solve the above problems, the present inventors have found that many causes are generation of bubbles at the time of detection, and have completed the present invention.

【0006】[0006]

【課題を解決するための手段】すなわち本発明は、次の
及びに関する。 試薬成分として可溶性の鎖式モノアルコールを含有す
るかまたは組み合わせてなる、抗原抗体反応を光学的な
濁度として測定する免疫学的測定試薬。 抗原抗体反応を光学的な濁度として測定する免疫学的
測定方法であって、測定時の反応液中に可溶性の鎖式モ
ノアルコールを存在させることを特徴とする免疫学的測
定方法。
That is, the present invention relates to the following and: An immunological measuring reagent for measuring an antigen-antibody reaction as an optical turbidity, which contains or combines a soluble chain monoalcohol as a reagent component. An immunological measuring method for measuring an antigen-antibody reaction as optical turbidity, which comprises allowing a soluble chain monoalcohol to exist in a reaction solution at the time of measurement.

【0007】以下、本発明を詳細に説明する。本発明の
免疫学的測定試薬は、可溶性の鎖式モノアルコールを含
有するが、構成試薬中の一成分として混合しておいても
良いし、別試薬として組み合わせて保存しておいても良
い。また、構成試薬が、複数個(例えば、試薬が希釈液
と抗血清液からなるもの)の場合、すべてに可溶性の鎖
式アルコールを含有させても良いし、一部の試薬のみに
含有させることも出来る。結局、測定時の反応液中に存
在させれば良い。本発明に使用する可溶性の鎖式モノア
ルコールとしては、メタノール、エタノール、n−プロ
ピルアルコール、イソプロピルアルコール、tert−ブチ
ルアルコール、イソブチルアルコール、sec−ブチルア
ルコール、n−アミルアルコール、イソアミルアルコー
ル、ヘキシルアルコール、ヘプチルアルコール、カプリ
ルアルコール、n−オクチルアルコール、ノニルアルコ
ール、デシルアルコール等の炭素数が1〜30の鎖式炭
化水素のモノアルコールが好ましく、特に炭素数が6以
上の鎖式モノアルコールが好ましい。中でも、n−オク
チルアルコールが最も効果が高く好ましい。
Hereinafter, the present invention will be described in detail. The immunological measurement reagent of the present invention contains a soluble chain monoalcohol, but may be mixed as one component of the constituent reagents or may be stored as a combination with another reagent. In addition, when there are multiple constituent reagents (for example, the reagent consists of a diluent and an antiserum solution), all may contain soluble chain alcohols, or only some reagents may contain them. You can also After all, it may be present in the reaction solution at the time of measurement. As the soluble chain monoalcohol used in the present invention, methanol, ethanol, n-propyl alcohol, isopropyl alcohol, tert-butyl alcohol, isobutyl alcohol, sec-butyl alcohol, n-amyl alcohol, isoamyl alcohol, hexyl alcohol, A chain hydrocarbon monoalcohol having 1 to 30 carbon atoms such as heptyl alcohol, capryl alcohol, n-octyl alcohol, nonyl alcohol, and decyl alcohol is preferable, and a chain monoalcohol having 6 or more carbon atoms is particularly preferable. Of these, n-octyl alcohol is the most effective and preferred.

【0008】試薬の一成分として、予め可溶性の鎖式モ
ノアルコールを含有し長期間保存する場合は、炭素数6
以上の鎖式高級モノアルコール又は炭素数6以上の鎖式
高級モノアルコール及び炭素数1〜5の鎖式低級モノア
ルコールの混合物が好ましい。可溶性の鎖式モノアルコ
ールの使用量は、充分な効果を示し且つ反応に悪影響を
与えないとの点から、反応時の存在量が反応液中に0.
001〜10%(v/v)、さらに0.001〜5%
(v/v)、特に0.001〜1%(v/v)となるよ
うに調製するのが好ましい。なお、炭素数1〜5程度の
低級モノアルコールは、測定時に使用すれば1%(v/
v)以下のごく微量でも効果を発揮するが、試薬の一成
分として混合して長期保存すると、揮発して時間と共に
その効果が弱くなるため、別試薬として保存しておき測
定時に使用することが好ましい。また、炭素数6以上の
高級モノアルコールでは粘度が高くなり本発明の効果を
充分に発揮出来なくなるため反応液中に10%(v/
v)以下で使用するのが好ましい。
When a chain monoalcohol soluble in advance is contained as one component of the reagent and is stored for a long period of time, it has 6 carbon atoms.
The above chain higher monoalcohol or a mixture of the chain higher monoalcohol having 6 or more carbon atoms and the chain lower monoalcohol having 1 to 5 carbon atoms is preferable. The amount of the soluble chain monoalcohol used is such that the amount present in the reaction during the reaction is 0.
001-10% (v / v), further 0.001-5%
(V / v), particularly preferably 0.001 to 1% (v / v). If a lower monoalcohol having about 1 to 5 carbon atoms is used at the time of measurement, 1% (v /
v) Even if it is a very small amount below, the effect will be exhibited, but if it is mixed as one component of the reagent and stored for a long time, it will volatilize and its effect will weaken with time, so it can be stored as another reagent and used for measurement. preferable. Further, a higher monoalcohol having 6 or more carbon atoms has a high viscosity, and the effect of the present invention cannot be sufficiently exerted, so that 10% (v / v)
v) It is preferably used below.

【0009】本発明の測定試薬の反応媒体としては、水
または生理的なNaCl濃度(0.1〜0.2M/リッ
トル)でpH(6〜9)の緩衝液が好ましいものとして使
用される。具体的な緩衝液としては、リン酸緩衝液、ほ
う酸緩衝液、グリシン緩衝液、トリス〔トリス(ヒドロ
キシメチル)アミノメタン〕塩酸緩衝液、アンモニア緩
衝液等の通常の生化学、免疫学の分野で使用される緩衝
液が使用でき、特に限定されない。また本発明の測定試
薬には、抗原抗体反応とその検出を妨害しない範囲で、
適宜、安定化剤、防腐剤、界面活性剤、キレ−ト剤、ポ
リエチレングリコール(PEG)、ポリビニルピロリド
ン(PVP)、ポリリジン等の反応促進剤等の添加物を
選択し含有させることが出来る。
As a reaction medium of the measuring reagent of the present invention, water or a buffer solution having a physiological NaCl concentration (0.1 to 0.2 M / liter) and a pH (6 to 9) is preferably used. Specific buffers include phosphate buffers, borate buffers, glycine buffers, tris [tris (hydroxymethyl) aminomethane] hydrochloric acid buffers, ammonia buffers, etc. in the fields of ordinary biochemistry and immunology. The buffer used can be used and is not particularly limited. In addition, the measurement reagent of the present invention, to the extent that it does not interfere with the antigen-antibody reaction and its detection,
Additives such as a stabilizer, a preservative, a surfactant, a chelating agent, a reaction accelerator such as polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and polylysine can be appropriately selected and contained.

【0010】本発明は、抗原抗体反応を光学的な濁度と
して測定するものであれば種々の免疫測定方法に適用で
き、その測定方法は限定されない。例えば、免疫比濁
法、ラテックス免疫比濁法、酵素免疫測定法、化学発光
酵素免疫測定法等が挙げられる。また、測定対象となる
抗原抗体反応も特に制限がなく、ヒト検体中(血中、尿
中)の種々の生体物質、例えば、血漿蛋白や種々の凝固
線溶系の蛋白、ホルモン、薬物、各種細菌、梅毒、クラ
ミジア、ウイルス等の抗原やこれらの抗体等、数多くの
測定項目に適用できる。
The present invention can be applied to various immunoassay methods as long as the antigen-antibody reaction is measured as optical turbidity, and the measurement method is not limited. For example, an immunoturbidimetric method, a latex immunoturbidimetric method, an enzyme immunoassay method, a chemiluminescent enzyme immunoassay method and the like can be mentioned. The antigen-antibody reaction to be measured is also not particularly limited, and various biological substances in human samples (blood, urine), such as plasma proteins and various coagulation / fibrinolytic system proteins, hormones, drugs, and various bacteria. It can be applied to a large number of measurement items such as antigens of syphilis, chlamydia, virus, etc. and their antibodies.

【0011】光学的な濁度の測定装置としては、通常の
分光光度計や生化学自動分析装置などを用いることがで
きる。また実際に測定する光は、いわゆる透過光でも散
乱光でも両者の併用でもよい。また、濁度の変化量は、
反応開始後一定時間後の1点で測定するワンポイントエ
ンド測定法、反応開始時と一定時間後の2点で測定する
ツーポイントエンド測定法、反応開始後の2点で測定す
るレート測定法、2点以上の時点で測定するマルチポイ
ント測定法等の方法で測定し、定量することができる。
また、本発明の測定方法において、光学的な濁度を測定
する波長は、測定装置、測定方法、担体粒子の使用の有
無、その場合の担体粒子の粒子径、反応成分の濃度等に
より適宜選択される。一般に、担体粒子を使用しない免
疫比濁法では、300〜400nm、担体粒子を使用する
ラテックス免疫比濁法などでは、400〜2400nmの
単色光又は多色光が用いられる。
As the optical turbidity measuring device, a usual spectrophotometer or biochemical automatic analyzer can be used. The light to be actually measured may be so-called transmitted light, scattered light, or a combination of both. The amount of change in turbidity is
One-point end measurement method that measures at one point after a certain time after the reaction starts, two-point end measurement method that measures at two points at the start of the reaction and after a certain time, rate measurement method that measures at two points after the reaction starts, It can be measured and quantified by a method such as a multipoint measuring method which measures at two or more points.
Further, in the measuring method of the present invention, the wavelength for measuring the optical turbidity is appropriately selected depending on the measuring device, the measuring method, the use or non-use of carrier particles, the particle diameter of the carrier particles in that case, the concentration of the reaction component, etc. To be done. Generally, monochromatic light or polychromatic light of 400 to 2400 nm is used in the immunoturbidimetric method that does not use carrier particles, and 300 to 400 nm in the latex immunoturbidimetric method that uses carrier particles.

【0012】[0012]

【実施例】以下、実施例により本発明を詳細に説明す
る。 実施例1〔血清中のアポ蛋白CIIの検出〕 下記のアポ蛋白CII免疫比濁試薬を調製し本発明の効果
を確認した。 1)測定試薬等の調製 a.希釈液 n−オクチルアルコールを0%、0.002%、0.0
1%、0.1%、1%、10%、50%(全てv/v)
のそれぞれの濃度で含有し、かつ0.15M塩化ナトリ
ウム、ポリエチレングリコール6000 4(v/v)
%を含有した20mMリン酸カリウム緩衝液(pH7.
3)を希釈液とした。 b.抗血清液 抗ヒトアポ蛋白CII IgG抗体を2%(w/v)含有
した0.02Mリン酸、0.15M塩化ナトリウム緩衝
液(pH7.3)を抗血清液とした。 c.アポ蛋白CII標準血清 アポ蛋白CII濃度0mg/dl、4.5mg/dlの2種類を用い
た。 d.検体 アポ蛋白CIIを含むヒト血清を用いた。
The present invention will be described in detail below with reference to examples. Example 1 [Detection of Apoprotein CII in Serum] The following apoprotein CII immunoturbidimetric reagent was prepared to confirm the effects of the present invention. 1) Preparation of measurement reagents, etc. a. Diluting liquid n-octyl alcohol 0%, 0.002%, 0.0
1%, 0.1%, 1%, 10%, 50% (all v / v)
Containing 0.15M sodium chloride and polyethylene glycol 6000 4 (v / v)
% 20 mM potassium phosphate buffer (pH 7.
3) was used as a diluent. b. Antiserum Solution 0.02M phosphoric acid containing 0.1% (w / v) of anti-human apoprotein CII IgG antibody, 0.15M sodium chloride buffer solution (pH 7.3) was used as an antiserum solution. c. Apoprotein CII standard serum Two types of apoprotein CII concentrations of 0 mg / dl and 4.5 mg / dl were used. d. Human serum containing apoprotein CII was used.

【0013】2)血清中のアポ蛋白CII測定(自動分析
装置) 日立7150形自動分析装置((株)日立製作所製)に
より測定した。分析条件は、以下の通りである。検体3
μlと各々n−オクチルアルコールを0〜50%(v/
v)含有した希釈液200μlを反応セル中に分注撹拌
し、5分間恒温(37℃)で保持した後、各反応セル中
に抗血清液200μlを分注撹拌し、更に5分間恒温
(37℃)で反応させた。検体添加後10分目と5分目
の吸光度(波長370nm)差を自動的に測定するツーポ
イントエンド法で行った。検量法は、予め前記アポ蛋白
CII標準血清(2種類)につき測定する2点検量法で行
った。同様の測定方法で被検検体を10回連続測定し上
記濃度を2点検量の結果より自動的に測定値として求め
平均値、標準偏差、変動係数を計算した。
2) Apoprotein CII measurement in serum (automatic analyzer) It was measured by a Hitachi 7150 type automatic analyzer (manufactured by Hitachi, Ltd.). The analysis conditions are as follows. Sample 3
μl and n-octyl alcohol each in an amount of 0 to 50% (v /
v) 200 μl of the contained diluent was dispensed and stirred in the reaction cell and kept at a constant temperature (37 ° C.) for 5 minutes, then 200 μl of the antiserum solution was dispensed and stirred in each reaction cell, and further incubated for 5 minutes at a constant temperature (37 ° C.). (° C). The two-point end method was used in which the difference in absorbance (wavelength 370 nm) 10 minutes and 5 minutes after the addition of the sample was automatically measured. The calibration method was a two-check method in which the apoprotein CII standard serum (two kinds) was measured in advance. The test sample was continuously measured 10 times by the same measurement method, and the above-mentioned concentration was automatically obtained as a measurement value from the results of the two inspection amounts, and the average value, standard deviation and coefficient of variation were calculated.

【0014】[0014]

【表1】 [Table 1]

【0015】[0015]

【発明の効果】本発明の免疫学的測定試薬を用いた測定
方法によれば、測定時に気泡の発生がなく、高精度で、
測定値のばらつきが少なく再現性の高い抗原抗体反応の
定量が可能である。
EFFECTS OF THE INVENTION According to the measuring method using the immunological measuring reagent of the present invention, bubbles are not generated during the measurement, and the measurement is highly accurate.
It is possible to quantify antigen-antibody reaction with high reproducibility with little variation in measured values.

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 試薬成分として可溶性の鎖式モノアルコ
ールを含有するかまたは組み合わせてなる、抗原抗体反
応を光学的な濁度として測定する免疫学的測定試薬。
1. An immunological measuring reagent for measuring an antigen-antibody reaction as optical turbidity, which contains or combines a soluble chain monoalcohol as a reagent component.
【請求項2】 鎖式モノアルコールが、炭素数1〜30
のものである請求項1記載の免疫学的測定試薬。
2. The chain monoalcohol has 1 to 30 carbon atoms.
The immunoassay reagent according to claim 1, which is
【請求項3】 鎖式モノアルコールが、炭素数6以上の
ものである請求項2記載の免疫学的測定試薬。
3. The immunoassay reagent according to claim 2, wherein the chain monoalcohol has 6 or more carbon atoms.
【請求項4】 鎖式モノアルコールが、n−オクチルア
ルコールである請求項1記載の免疫学的測定試薬。
4. The immunoassay reagent according to claim 1, wherein the chain monoalcohol is n-octyl alcohol.
【請求項5】 抗原抗体反応を光学的な濁度として測定
する免疫学的測定方法であって、測定時の反応液中に可
溶性の鎖式モノアルコールを存在させることを特徴とす
る免疫学的測定方法。
5. An immunological measuring method for measuring an antigen-antibody reaction as optical turbidity, wherein a soluble chain monoalcohol is present in a reaction solution at the time of measurement. Measuring method.
【請求項6】 鎖式モノアルコールの存在量を反応液中
に0.001〜10%(v/v)とする請求項5記載の
免疫学的測定方法。
6. The immunological assay method according to claim 5, wherein the amount of the chain monoalcohol present is 0.001 to 10% (v / v) in the reaction solution.
【請求項7】 鎖式モノアルコールが、炭素数1〜30
のものである請求項5または6記載の免疫学的測定方
法。
7. The chain monoalcohol has 1 to 30 carbon atoms.
The immunological assay method according to claim 5 or 6, wherein
【請求項8】 鎖式モノアルコールが、n−オクチルア
ルコールである請求項5、6または7記載の免疫学的測
定方法。
8. The immunological assay method according to claim 5, 6 or 7, wherein the chain monoalcohol is n-octyl alcohol.
JP14621394A 1994-06-28 1994-06-28 Immunological determination reagent and determination method Pending JPH0815258A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14621394A JPH0815258A (en) 1994-06-28 1994-06-28 Immunological determination reagent and determination method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14621394A JPH0815258A (en) 1994-06-28 1994-06-28 Immunological determination reagent and determination method

Publications (1)

Publication Number Publication Date
JPH0815258A true JPH0815258A (en) 1996-01-19

Family

ID=15402676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14621394A Pending JPH0815258A (en) 1994-06-28 1994-06-28 Immunological determination reagent and determination method

Country Status (1)

Country Link
JP (1) JPH0815258A (en)

Similar Documents

Publication Publication Date Title
Killingsworth et al. Nephelometric studies of the precipitin reaction: a model system for specific protein measurements
US4766083A (en) Method for the photometric determination of biological agglutination
US4536478A (en) Method for reducing non-specific interferences in agglutination immunoassays
JPH03502246A (en) Coagulation methods for the analysis of substances
EP0222341B1 (en) A method for immunoassay and reagents therefor
EP1801590A1 (en) Method of assaying antigen and reagent therefor
Gella et al. Latex agglutination procedures in immunodiagnosis
JPS6365369A (en) Method for measuring antigen-antibody reaction
Buffone et al. Use of a laser-equipped centrifugal analyzer for kinetic measurement of serum IgG
EP0269526B1 (en) Method of quantitative determination of antigens and antibodies
US8900882B2 (en) Method of assaying complex and kit to be used therefor
JP3513075B2 (en) Immunoassay and reagent therefor
JPH0566548B2 (en)
EP0439611B1 (en) Method for assaying immunologically active substance and reagent therefor
JPH0815258A (en) Immunological determination reagent and determination method
JPH0448265A (en) Immunoassay
JP3618797B2 (en) Immunoassay
JPH0712818A (en) Immunological detection
JP3048306B2 (en) Fibrin degradation product and / or fibrinogen degradation product measuring reagent and method for quantifying the same
Montagne et al. Polyacrylic microspheres as a solid phase for microparticle enhanced nephelometric immunoassay (NEPHELIA (R)) of transferrin
EP0433629B1 (en) A method for the qualitative and quantitative determination of antibodies against bacterial antigens by means of the photometric measurement of agglutination
WO2024038863A1 (en) Immunoassay method and reagent
JPH10104233A (en) Assay of human anti-thorombin iii and its measuring kit
JPH11258239A (en) Reagent and method for immunoagglutination test
JPH02147957A (en) Determination of antigen or antibody